C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/06 (2006.01) A61K 31/495 (2006.01) A61K 31/535 (2006.01) C07D 235/14 (2006.01) C07D 401/14 (2006.01) C07D 403/14 (2006.01) C07D 409/12 (2006.01) C07D 409/14 (2006.01)
Patent
CA 2159220
A class of benzimidazole derivatives, substituted at the 2-position by a substituted piperazinylmethyl or pirerazinylethyl moiety, are antagonists of dopamine receptor subtypes within the brain, having a selective affinity for the dopamine D4 receptor subtype over other dopamine receptor subtypes, and are accordingly of benefit in the treatment and/or prevention of psychotic disorders such as schizophrenia whilst manifesting fewer side-effects than those associated with classical neuroleptic drugs.
Kulagowski Janusz Jozef
Leeson Paul David
Merck Sharp & Dohme Limited
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Antipsychotic benzimidazole derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antipsychotic benzimidazole derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antipsychotic benzimidazole derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1465355